BR112013029144A2 - uso de uma composição, método para estimular uma resposta imune inata em um indivíduo, método para proteger um indivíduo contra infecção microbiana, método para tratar uma infecção crônica ou recorrente e kit - Google Patents
uso de uma composição, método para estimular uma resposta imune inata em um indivíduo, método para proteger um indivíduo contra infecção microbiana, método para tratar uma infecção crônica ou recorrente e kitInfo
- Publication number
- BR112013029144A2 BR112013029144A2 BR112013029144A BR112013029144A BR112013029144A2 BR 112013029144 A2 BR112013029144 A2 BR 112013029144A2 BR 112013029144 A BR112013029144 A BR 112013029144A BR 112013029144 A BR112013029144 A BR 112013029144A BR 112013029144 A2 BR112013029144 A2 BR 112013029144A2
- Authority
- BR
- Brazil
- Prior art keywords
- individual
- infection
- stimulating
- chronic
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26041—Use of virus, viral particle or viral elements as a vector
- C12N2770/26042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485955P | 2011-05-13 | 2011-05-13 | |
| PCT/CA2012/050278 WO2012155261A1 (en) | 2011-05-13 | 2012-05-01 | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013029144A2 true BR112013029144A2 (pt) | 2017-07-11 |
Family
ID=47176093
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013029144A BR112013029144A2 (pt) | 2011-05-13 | 2012-05-01 | uso de uma composição, método para estimular uma resposta imune inata em um indivíduo, método para proteger um indivíduo contra infecção microbiana, método para tratar uma infecção crônica ou recorrente e kit |
| BR112013029143A BR112013029143A2 (pt) | 2011-05-13 | 2012-05-01 | processo in vitro para o preparo de partículas similares a vírus e seu uso, partícula similar a vírus de vírus do mosaico do mamoeiro, composição farmacêutica e método para acentuar uma resposta imune a um antígeno e para estimular a resposta imune inata em um indivíduo |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013029143A BR112013029143A2 (pt) | 2011-05-13 | 2012-05-01 | processo in vitro para o preparo de partículas similares a vírus e seu uso, partícula similar a vírus de vírus do mosaico do mamoeiro, composição farmacêutica e método para acentuar uma resposta imune a um antígeno e para estimular a resposta imune inata em um indivíduo |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140154288A1 (https=) |
| EP (2) | EP2707480B1 (https=) |
| JP (2) | JP6093926B2 (https=) |
| CN (2) | CN103648528A (https=) |
| AU (1) | AU2012255595A1 (https=) |
| BR (2) | BR112013029144A2 (https=) |
| CA (2) | CA2835972A1 (https=) |
| DK (1) | DK2707480T3 (https=) |
| MX (1) | MX2013013228A (https=) |
| NO (1) | NO2800866T3 (https=) |
| WO (2) | WO2012155262A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140154288A1 (en) | 2011-05-13 | 2014-06-05 | Folia Biotech Inc. | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
| JP2016531927A (ja) * | 2013-09-19 | 2016-10-13 | フォリア バイオテック インコーポレイテッド | 癌治療でのパパイヤモザイクウイルス及びウイルス様粒子 |
| WO2015153883A1 (en) * | 2014-04-02 | 2015-10-08 | Case Western Reserve University | Vaccination using plant virus particles linked to her2 antigens |
| US11998594B2 (en) | 2014-04-02 | 2024-06-04 | Case Western Reserve University | Anti-cancer plant virus particles linked to HER2 antigens |
| CN107002085A (zh) * | 2014-09-11 | 2017-08-01 | 卡迪拉保健有限公司 | 具有优异免疫学特性的优异的人乳头瘤病毒抗原和含有其的疫苗 |
| WO2016127262A1 (en) * | 2015-02-12 | 2016-08-18 | Folia Biotech Inc. | Multimerized orthomyxovirus nucleoprotein and uses thereof |
| GB201708709D0 (en) | 2017-06-01 | 2017-07-19 | Univ York | Virus like particle |
| MX385484B (es) * | 2017-06-28 | 2025-03-14 | Univ Mexico Nac Autonoma | Vlps derivadas de virus de planta con dsrna encapsidado y metodo de sintesis. |
| FR3106648B1 (fr) * | 2020-01-28 | 2022-05-27 | Arkema France | Structure multicouche pour le transport ou le stockage de l’hydrogene |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443969A (en) | 1992-10-29 | 1995-08-22 | Rutgers University | RNA packaging system |
| US8101189B2 (en) * | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
| JP4953570B2 (ja) | 2002-07-05 | 2012-06-13 | フォリア バイオテック インコーポレイテッド | アジュバントウィルス粒子 |
| EP1644034B1 (en) * | 2003-07-10 | 2011-01-12 | Cytos Biotechnology AG | Composition for enhancing an immune response comprising packaged virus-like particles |
| ATE472336T1 (de) | 2003-10-22 | 2010-07-15 | Id Biomedical Corp Quebec | Zusammensetzungen und verfahren zur aktivierung der eigenen und allergischen immunität |
| DK2069503T3 (da) * | 2006-11-15 | 2016-02-15 | Folia Biotech Inc | Papayamosaikvirus-baserede vacciner mod influenza |
| CA2669345A1 (en) * | 2006-11-15 | 2008-05-22 | Folia Biotech Inc. | Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| US7799281B2 (en) | 2007-01-16 | 2010-09-21 | Festo Corporation | Flux concentrator for biomagnetic particle transfer device |
| WO2008089569A1 (en) * | 2007-01-26 | 2008-07-31 | Folia Biotech Inc. | Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| CA2742288A1 (en) | 2008-07-30 | 2010-02-04 | Folia Biotech Inc. | Multivalent vaccines based on papaya mosaic virus and uses thereof |
| WO2010030790A2 (en) | 2008-09-10 | 2010-03-18 | The Texas A&M University System | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| US20140154288A1 (en) | 2011-05-13 | 2014-06-05 | Folia Biotech Inc. | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
-
2012
- 2012-05-01 US US14/117,363 patent/US20140154288A1/en not_active Abandoned
- 2012-05-01 EP EP12785518.7A patent/EP2707480B1/en not_active Not-in-force
- 2012-05-01 JP JP2014509576A patent/JP6093926B2/ja not_active Expired - Fee Related
- 2012-05-01 DK DK12785518.7T patent/DK2707480T3/da active
- 2012-05-01 BR BR112013029144A patent/BR112013029144A2/pt not_active IP Right Cessation
- 2012-05-01 CA CA2835972A patent/CA2835972A1/en not_active Abandoned
- 2012-05-01 WO PCT/CA2012/050279 patent/WO2012155262A1/en not_active Ceased
- 2012-05-01 AU AU2012255595A patent/AU2012255595A1/en not_active Abandoned
- 2012-05-01 WO PCT/CA2012/050278 patent/WO2012155261A1/en not_active Ceased
- 2012-05-01 US US14/117,365 patent/US9833504B2/en active Active
- 2012-05-01 CN CN201280023824.XA patent/CN103648528A/zh active Pending
- 2012-05-01 MX MX2013013228A patent/MX2013013228A/es not_active Application Discontinuation
- 2012-05-01 JP JP2014509577A patent/JP6213461B2/ja not_active Expired - Fee Related
- 2012-05-01 EP EP12786315.7A patent/EP2707027A4/en not_active Withdrawn
- 2012-05-01 BR BR112013029143A patent/BR112013029143A2/pt not_active IP Right Cessation
- 2012-05-01 CA CA2835967A patent/CA2835967A1/en not_active Abandoned
- 2012-05-01 CN CN201280022947.1A patent/CN103687942A/zh active Pending
-
2013
- 2013-01-04 NO NO13700794A patent/NO2800866T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2707480B1 (en) | 2017-08-02 |
| CN103648528A (zh) | 2014-03-19 |
| EP2707027A1 (en) | 2014-03-19 |
| US20140154288A1 (en) | 2014-06-05 |
| CN103687942A (zh) | 2014-03-26 |
| US20140255439A1 (en) | 2014-09-11 |
| WO2012155262A1 (en) | 2012-11-22 |
| CA2835972A1 (en) | 2012-11-22 |
| US9833504B2 (en) | 2017-12-05 |
| BR112013029143A2 (pt) | 2017-07-11 |
| AU2012255595A1 (en) | 2013-12-12 |
| CA2835967A1 (en) | 2012-11-22 |
| JP2014514350A (ja) | 2014-06-19 |
| EP2707480A1 (en) | 2014-03-19 |
| MX2013013228A (es) | 2013-12-12 |
| JP6093926B2 (ja) | 2017-03-15 |
| JP6213461B2 (ja) | 2017-10-18 |
| WO2012155261A1 (en) | 2012-11-22 |
| EP2707480A4 (en) | 2015-01-07 |
| JP2014519817A (ja) | 2014-08-21 |
| EP2707027A4 (en) | 2015-06-03 |
| DK2707480T3 (da) | 2017-11-13 |
| NO2800866T3 (https=) | 2018-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013029144A2 (pt) | uso de uma composição, método para estimular uma resposta imune inata em um indivíduo, método para proteger um indivíduo contra infecção microbiana, método para tratar uma infecção crônica ou recorrente e kit | |
| BR112014010162A2 (pt) | uso de composição, método para melhorar o reconhecimento e/ou tratar ou prevenir função de reconhecimento prejudicada em um indivíduo, e composição | |
| PT2825161T (pt) | Inibidores de ezh2 humana e métodos de uso dos mesmos | |
| AR089993A1 (es) | Macrociclos peptidomimeticos | |
| BR112014009837A2 (pt) | uso eficaz da levedura e extrato de levedura | |
| BR112014002547A2 (pt) | bomba de infusão com válvulas independentemente controláveis e operação de baixa potência e seus métodos | |
| PT2709522T (pt) | Sistemas para reabilitação neurofisiológica e/ou desenvolvimento funcional com efeito sinérgico | |
| BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
| BR112014001221A2 (pt) | método e uso de histamina bacteriana | |
| DK2529756T3 (da) | Risperidon- og/eller paliperidon-implantatformulering | |
| BR112013019083A2 (pt) | combinação de (a) um imunoconjugado, composição farmacêutica, uso de (a) um imunoconjugado, método de tratamento de uma doença em um individuo, método de estímulo de função celular efetora em um indivíduo e kit destinado ao tratamento de uma doença. | |
| SI2729151T1 (sl) | Farmacevtski sestavek, postopki za zdravljenje in njihove uporabe | |
| GB2497474B (en) | Method and appartus for enhancing the accuracy of the estimated covariance matrix in wideband-CDMA systems | |
| BR112012028719A2 (pt) | composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano a uma superfície dura e uso de uma combinação | |
| BR112014014004A2 (pt) | métodos e composições para redução de gordura corporal e adipócitos | |
| BR112015005400A2 (pt) | formulação de daptomicina liofilizada, método para tratar uma infecção bacteriana em um indivíduo, método para tratar ou prevenir um biofilme e método para preparar uma formulação de daptomicina liofilizada | |
| BR112013022766A2 (pt) | método de administração de d-pirfenidona e kit | |
| BR112012027531A2 (pt) | método de tratamento e/ou prevenção de progresso e/ou atraso de desenvolvimento de hepatite em um indivíduo, uso de uma molécula imunológica anti-cd3 e composição farmacêutica | |
| BR112014009822A2 (pt) | composições farmacêuticas compreendendo dgla e/ou 15-hetre e métodos de uso dos mesmos | |
| SG10201709955PA (en) | Methods of treatment and compositions with xanthine oxidase inhibitors | |
| BR112014025507A2 (pt) | formulação vesicular e método de tratamento | |
| BRPI0820258A2 (pt) | composto, composições de vacina e farmacêutica, e , métodos para estimular uma resposta imune em um indivíduo e para tratar um indivíduo | |
| BR112014013613A2 (pt) | composição antimicrobiana, método de desinfecção de uma superfície e uso de uma composição | |
| BR112013034066A2 (pt) | método de administração e tratamento | |
| ZA201409073B (en) | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |